Liu Xing-Pan, Shen Jing, Li Zhen-Fu, Yan Li, Gu Jin
Department of Surgery, Beijing Cancer Hospital, School of Oncology, Peking University, Beijing, China.
Cancer Invest. 2006 Dec;24(8):747-53. doi: 10.1080/07357900601063873.
New serum biomarkers are needed to improve the early detection of colorectal adenocarcinoma. We performed surface enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS) to screen for differentially expressed proteins in serum and build a proteomic diagnostic pattern for the detection of colorectal adenocarcinoma to improve the prognosis of patients with this disease.
In an attempt to improve current approaches to the serologic diagnosis of colorectal cancer, we analyzed serum samples from subjects with or without colorectal cancer using SELDI-MS. Using a case-control study design, SELDI-MS profile of serum samples from 74 colorectal adenocarcinoma patients were compared with 48 age-and sex-matched healthy subjects using a ProteinChip reader, PBSII-C. Proteomic MS spectra were generated using IMAC3 chips, and protein peaks clustering and classification analyses were performed to build a proteomic pattern that could differentiate patients with colorectal adenocarcinoma from healthy subjects utilizing Biomarker Wizard and Biomarker Patterns software packages, respectively. The constructed pattern was then used to test an independent set of masked serum samples from 60 colorectal cancer patients and 39 healthy subjects.
Among the differentially expressed protein peaks identified by SELDI-MS profiling that had the ability to distinguish between patients and healthy subjects, we determined a minimum set of two protein peaks for system training and for developing a decision classification pattern. Masked analysis of an independent set of serum samples showed the diagnostic pattern could differentiate patients with different stages of colorectal cancer from healthy subjects with a sensitivity of 95.00 percent and specificity of 94.87 percent.
SELDI-TOF-MS profiling of serum proteins combined with bioinformatics tools can be applied to accurately differentiate patients with colorectal cancer from healthy subjects. The high sensitivity and specificity achieved by the constructed clustering analysis algorithm show great potential for the early detection of colorectal cancer.
需要新的血清生物标志物来改善结直肠癌的早期检测。我们进行了表面增强激光解吸电离飞行时间质谱分析(SELDI - TOF - MS),以筛选血清中差异表达的蛋白质,并建立用于检测结直肠癌的蛋白质组学诊断模式,从而改善该疾病患者的预后。
为了改进目前结直肠癌血清学诊断方法,我们使用SELDI - MS分析了患有或未患结直肠癌受试者的血清样本。采用病例对照研究设计,使用ProteinChip阅读器PBSII - C将74例结直肠癌患者的血清样本的SELDI - MS图谱与48例年龄和性别匹配的健康受试者的图谱进行比较。使用IMAC3芯片生成蛋白质组质谱图,并分别使用Biomarker Wizard和Biomarker Patterns软件包进行蛋白质峰聚类和分类分析,以建立能够区分结直肠癌患者和健康受试者的蛋白质组模式。然后使用构建的模式测试来自60例结直肠癌患者和39例健康受试者的一组独立的盲法血清样本。
在通过SELDI - MS分析鉴定出的能够区分患者和健康受试者的差异表达蛋白质峰中,我们确定了用于系统训练和制定决策分类模式的最少两个蛋白质峰组合。对一组独立血清样本的盲法分析表明,该诊断模式能够将不同阶段的结直肠癌患者与健康受试者区分开来,灵敏度为95.00%,特异性为94.87%。
血清蛋白质的SELDI - TOF - MS分析结合生物信息学工具可用于准确区分结直肠癌患者和健康受试者。构建的聚类分析算法所实现的高灵敏度和特异性显示出在结直肠癌早期检测方面的巨大潜力。